flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Preventing chronic disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global (KDIGO) Controversies Conference WCN25-1900 Clinical and Safety Outcomes
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



























